{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:27:45Z","timestamp":1775107665393,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144969","type":"journal-article","created":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T13:41:00Z","timestamp":1451310060000},"page":"e0144969","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo"],"prefix":"10.1371","volume":"10","author":[{"given":"Jia","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiachun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiruvengadam","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Defeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoshen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig D.","family":"Logsdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"RL Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"ref2","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1200\/JCO.2007.11.3431","article-title":"Recent major progress in long-term cancer patient survival disclosed by modeled period analysis","volume":"25","author":"H Brenner","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"A Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"Cavalcante L de Sousa","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2011.11.029","article-title":"Combinational therapy: New hope for pancreatic cancer?","volume":"317","author":"S Shi","year":"2012","journal-title":"Cancer Lett"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5414\/CPP47046","article-title":"Classical resistance mechanisms","volume":"47","author":"W J\u00e4eger","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.20831","article-title":"Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma","volume":"115","author":"J K\u00f6nig","year":"2005","journal-title":"Int J Cancer"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3892\/ijo.2013.1839","article-title":"Emodin sensitizes the gemcitabine-resistant cell line Bxpc-3\/Gem to gemcitabine via downregulation of NF-\u03baB and its regulated targets","volume":"42","author":"W Zhang","year":"2013","journal-title":"Int J Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1038\/oncsis.2013.16","article-title":"MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes","volume":"2","author":"S Nath","year":"2013","journal-title":"Oncogenesis"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1110\/ps.9.8.1594","article-title":"The L6 membrane proteins-a new four-transmembrane superfamily","volume":"9","author":"MD Wright","year":"2000","journal-title":"Protein Sci"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/pros.21340","article-title":"TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration","volume":"71","author":"N Allioli","year":"2011","journal-title":"Prostate"},{"issue":"8","key":"ref12","first-page":"3917","article-title":"Monoclonal mouse antibodies raised against human lung carcinoma","volume":"46","author":"I Hellstr\u00f6m","year":"1986","journal-title":"Cancer Res"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1158\/0008-5472.CAN-08-4886","article-title":"The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis","volume":"69","author":"SC Shih","year":"2009","journal-title":"Cancer Res"},{"issue":"Pt5","key":"ref14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1242\/jcs.020347","article-title":"The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility","volume":"121","author":"T Lekishvili","year":"2008","journal-title":"J Cell Sci"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1158\/1535-7163.MCT-15-0188","article-title":"Novel Anti-TM4SF1 Antibody Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature","volume":"14","author":"A Visintin","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64800-6","article-title":"Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype","volume":"157","author":"H Ouyang","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral- mediated delivery of small interfering RNA against CCR5","volume":"100","author":"XF Qin","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/0008-5472.CAN-06-3362","article-title":"Adrenomedullin expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR","volume":"67","author":"V Ramachandran","year":"2007","journal-title":"Cancer Res"},{"issue":"14","key":"ref19","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"T Arumugam","year":"2009","journal-title":"Cancer Res"},{"issue":"15","key":"ref20","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1158\/1078-0432.CCR-05-0092","article-title":"S100P promotes pancreatic cancer growth, survival, and invasion","volume":"11","author":"T Arumugam","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-03-3863","article-title":"Activation of the platelet-derived growth factor receptor enhances survival of murine bone endothelial cells","volume":"64","author":"RR Langley","year":"2004","journal-title":"Cancer Res"},{"issue":"10","key":"ref22","first-page":"2649","article-title":"Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer","volume":"63","author":"CD Logsdon","year":"2003","journal-title":"Cancer Res"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc1817","article-title":"New roles for integrins in squamous-cell carcinoma","volume":"6","author":"SM Janes","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.1990.8.6.1083","article-title":"Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer","volume":"8","author":"GE Goodman","year":"1990","journal-title":"J Clin Oncol"},{"issue":"23","key":"ref25","first-page":"5916s","article-title":"Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions","volume":"55","author":"CM Richman","year":"1995","journal-title":"Cancer Res"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1073\/pnas.94.8.4000","article-title":"Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts","volume":"94","author":"SJ DeNardo","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1158\/0008-5472.CAN-08-4886","article-title":"The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis","volume":"69","author":"SC Shih","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10456-014-9437-2","article-title":"TM4SF1: a new vascular therapeutic target in cancer","volume":"17","author":"CI Lin","year":"2014","journal-title":"Angiogenesis"},{"key":"ref29","first-page":"986","article-title":"TM4SF1 stimulates pancreatic cancer cell migration and invasion","volume":"38","author":"J Cao","year":"2009","journal-title":"Pancreas"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/ijo.2013.2189","article-title":"hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration","volume":"44","author":"L Xu","year":"2014","journal-title":"Int J Oncol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"MM Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"4B","key":"ref32","first-page":"2115","article-title":"MDR1\/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma","volume":"27","author":"L O\u2019Driscoll","year":"2007","journal-title":"Anticancer Res"},{"issue":"20","key":"ref33","first-page":"1743","article-title":"Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer","volume":"120","author":"YP Zhao","year":"2007"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006676-200010000-00004","article-title":"Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer","volume":"21","author":"Z Lu","year":"2000","journal-title":"Pancreas"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ar.22552","article-title":"Reversal of multidrug resistance by gefitinib via RAF1\/ERK pathway in pancreatic cancer cell line","volume":"295","author":"Z Xiao","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI33768","article-title":"Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma","volume":"118","author":"SA Lee","year":"2008","journal-title":"J Clin Invest"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbamcr.2011.11.017","article-title":"Gefitinib resistance of cancer cells correlated with TM4SF5\u2014mediated epithelial-mesenchymal transition","volume":"1823","author":"MS Lee","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2011.09.030","article-title":"JNK signaling activity regulates cell-cell adhesions via TM4SF5-mediated p27<sup>kip1<\/sup> phosphorylation","volume":"314","author":"H Kim","year":"2012","journal-title":"Cancer Lett"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbamcr.2010.04.001","article-title":"TM4SF5 accelerates G1\/S phase progression via cytosolic p27<sup>kip1<\/sup> expression and RhoA activity","volume":"1803","author":"H Kim","year":"2010","journal-title":"Biochim Biophys Acta"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T20:26:10Z","timestamp":1567455970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144969"}},"subtitle":[],"editor":[{"given":"James","family":"Freeman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144969","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}